Moreover, data coming from retrospective studies in patients with breast cancer indicated that high VEGF levels in breast tumor tissue were associated with decreased responsiveness to hormonal therapy in both adjuvant and metastatic breast cancer patients[20,21]. This evidence concerns the gene VEGFA and breast neoplasm.